About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Drug Delivery System for Niemann Pick Type C1 Disease Discovered

by Julia Samuel on August 31, 2016 at 10:19 PM
Font : A-A+

Drug Delivery System for Niemann Pick Type C1 Disease Discovered

A type of drug delivery system that may offer new hope for patients with a rare, ultimately fatal genetic disorder has been discovered by researchers at Oregon State University.

No treatment currently exists for this disease, known as Niemann Pick Type C1 disease, or NPC1, that affects about one in every 120,000 children globally, and results in abnormal cholesterol accumulation, progressive neurodegeneration and eventual death.

Advertisement


However, a compound that shows promise is now undergoing clinical trials, but it has major drawbacks - the high doses necessary also cause significant hearing loss and lung damage, as well as requiring direct brain injection.

The same system, they say, may ultimately show similar benefits for 50 or more other genetic disorders, especially those that require "brain targeting" of treatments.
Advertisement

"Right now there's nothing that can be done for patients with this disease, and the median survival time is 20 years," said Gaurav Sahay, an assistant professor in the Oregon State University/Oregon Health & Science University College of Pharmacy, and corresponding author on the new study.

"The new cholesterol-scavenging drug proposed to treat this disorder, called cyclodextrin may for the first time offer a real treatment. But it can cause significant hearing loss and requires multiple injections directly into the brain, which can be very traumatic. I'm very excited about the potential of our new drug delivery system to address these problems."

In this approach, the HPβCD drug is attached to an extraordinarily small, nanotech-sized lipid particle that can carry it into cells, where it helps to flush out cholesterol. Researchers were surprised to discover, however, that the carrier itself also helped address the problem, while working in synergy with the drug it carries to greatly increase its effectiveness.

This should allow use of much lower dosages, Sahay said, and possibly an easier delivery through intravenous injection, instead of brain injection. In the form currently used, only 0.2 percent of the drug is able to cross the blood brain barrier.

In previous research with the HPβCD drug in animal models, the treatment did slow the progression of this disease, but did not reverse it. The disease focuses its damage on liver and brain cells.

In their report, researchers noted that this type of drug delivery system has several advantages, including prolonged circulation times, the ability to incorporate multiple drugs with different mechanisms of action, and a variety of "targeting ligands" that can help cross the blood brain barrier.

The researchers have also partnered with Dr. Edward Neuwelt at the OHSU Blood Brain Barrier Program, who has pioneered temporary opening of the blood brain barrier in humans to access drugs to the brain.

"Taken together, nanocarriers can serve as a platform that can effectively deliver small molecules, genes and perhaps imaging agents for treatment and diagnosis of a wide variety of other rare lysosomal storage disorders," the researchers wrote in their conclusion.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Heart Day in 2022- Use Heart for Every Heart
Anemia among Indian Women and Children Remains a Cause of Concern- National Family Health Survey-5
H1N1 Influenza Prevention in Children: What Parents Need to Know
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Drug Toxicity Otitis Media Signature Drug Toxicity Drugs Banned in India Nanotechnology Drug Delivery System Oncology Drug Delivery Systems Drug Delivery Systems - Use in Diabetes Management Cholesteryl Ester Storage Disease 3D Printing in the Pharmaceutical Industry: Technology and Future 

Most Popular on Medindia

Noscaphene (Noscapine) Drug Interaction Checker Pregnancy Confirmation Calculator Blood - Sugar Chart Find a Hospital Loram (2 mg) (Lorazepam) Drug Side Effects Calculator A-Z Drug Brands in India Daily Calorie Requirements Nutam (400mg) (Piracetam)
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Drug Delivery System for Niemann Pick Type C1 Disease Discovered Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests